# A Phase II Study of H56:IC31 in Healthy Adolescents

> **NCT03265977** · PHASE2 · WITHDRAWN · sponsor: **Aeras**

## Conditions studied

- Tuberculosis Infection

## Interventions

- **BIOLOGICAL:** H56:IC31
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03265977
- **Lead sponsor:** Aeras
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-06
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Design, sponsorship changed prior to initiation. No study procedures done.
- **Last updated:** 2018-04-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03265977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03265977, "A Phase II Study of H56:IC31 in Healthy Adolescents". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03265977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*